BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Diagnosis
11 results:

  • 1. Loss of ATRX expression predicts worse prognosis in pulmonary carcinoid tumors.
    Terra Md SBSP; Xie Md PhD H; Boland Md JM; Mansfield Md AS; Molina Md PhD JR; Roden Md AC
    Hum Pathol; 2019 Dec; 94():78-85. PubMed ID: 31499081
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. cancer diagnoses after emergency GP referral or A&E attendance in England: determinants and time trends in Routes to diagnosis data, 2006-2015.
    Herbert A; Abel GA; Winters S; McPhail S; Elliss-Brookes L; Lyratzopoulos G
    Br J Gen Pract; 2019 Oct; 69(687):e724-e730. PubMed ID: 31455644
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Superparamagnetic iron-oxide-enhanced diffusion-weighted magnetic resonance imaging for the diagnosis of intrapancreatic accessory spleen.
    Ishigami K; Nishie A; Nakayama T; Asayama Y; Kakihara D; Fujita N; Ushijima Y; Okamoto D; Ohtsuka T; Mori Y; Ito T; Mochidome N; Honda H
    Abdom Radiol (NY); 2019 Oct; 44(10):3325-3335. PubMed ID: 31420705
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma.
    Zhou CY; Dong YP; Sun X; Sui X; Zhu H; Zhao YQ; Zhang YY; Mason C; Zhu Q; Han SX
    Cancer Med; 2018 Nov; 7(11):5525-5533. PubMed ID: 30358133
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Predictive Value of Serum Carbohydrate Antigen 19-9 (CA19-9) for Early Mortality in Advanced pancreatic cancer.
    Usón Junior PLS; Callegaro-Filho D; Bugano DDG; Moura F; Maluf FC
    J Gastrointest Cancer; 2018 Dec; 49(4):481-486. PubMed ID: 28924968
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea.
    Jang WI; Kim MS; Kang SH; Jo AJ; Kim YJ; Tchoe HJ; Park CM; Kim HJ; Choi JA; Choi HJ; Paik EK; Seo YS; Yoo HJ; Kang JK; Han CJ; Kim YJ; Kim SB; Ko MJ
    Oncotarget; 2017 Feb; 8(6):9587-9596. PubMed ID: 28077783
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. diagnosis of pancreatic carcinoma based on combined measurement of multiple serum tumor markers using artificial neural network analysis.
    Yang Y; Chen H; Wang D; Luo W; Zhu B; Zhang Z
    Chin Med J (Engl); 2014; 127(10):1891-6. PubMed ID: 24824251
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Serum carbohydrate antigen 242 expression exerts crucial function in the diagnosis of pancreatic cancer.
    Li X; Guo X; Li H; Lin H; Sun Y
    Tumour Biol; 2014 Jun; 35(6):5281-6. PubMed ID: 24510349
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The incidence and survival rate of population-based pancreatic cancer patients: Shanghai cancer Registry 2004-2009.
    Luo J; Xiao L; Wu C; Zheng Y; Zhao N
    PLoS One; 2013; 8(10):e76052. PubMed ID: 24130758
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis.
    Gui JC; Yan WL; Liu XD
    Clin Exp Med; 2014 May; 14(2):225-33. PubMed ID: 23456571
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The effect of depression on stage at diagnosis, treatment, and survival in pancreatic adenocarcinoma.
    Boyd CA; Benarroch-Gampel J; Sheffield KM; Han Y; Kuo YF; Riall TS
    Surgery; 2012 Sep; 152(3):403-13. PubMed ID: 22938900
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.